Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06034951
Other study ID # Compleat002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 24, 2023
Est. completion date December 22, 2023

Study information

Verified date April 2024
Source Société des Produits Nestlé (SPN)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Enterally fed adults and children who are assessed by the dietitian as requiring an adult high-energy, fibre-containing enteral formula will be recruited. Data from 15 participants are required in order to submit an application to the Advisory Committee on Borderline Substances (ACBS) for product registration.


Description:

To evaluate the acceptability (including gastrointestinal tolerance and compliance) of a high energy, adult enteral formula with food-derived ingredients.This is a single arm, prospective, multi-centre study to evaluate the gastrointestinal tolerance and compliance over a 14-day period with the new tube feed. Participants or their caregivers will be provided with 14-day supply of the new tube feed and will be asked to complete a daily diary and short questionnaire to record information allowing assessment of the following: - Gastrointestinal tolerance - Compliance with prescribed feed volume


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date December 22, 2023
Est. primary completion date August 21, 2023
Accepts healthy volunteers No
Gender All
Age group 15 Years and older
Eligibility Inclusion Criteria: - Patients requiring an enteral tube feed (taking > 60% of energy needs from their feeding tube) as part of their dietary management for disease related malnutrition - Children 15 years and over - Adults and children requiring an adult high-energy and fibre-containing formula, as assessed by the dietitian. - Patients well-established and stable on enteral feeding. - Willingly given, written, informed consent from patient or consultee - Willingly given, written assent (if appropriate). Exclusion Criteria: - Inability to comply with the study protocol, in the opinion of the investigator - Children under 15 years of age - Patients receiving mechanical ventilation, sedation or inotropic support - Patients on total parenteral nutrition - Known food allergies to any ingredients (see ingredients list) or galactosaemia - Patients with significant renal or hepatic impairment - Patients with planned changes to medication or treatments during the study period which may alter gastrointestinal function (e.g. chemotherapy). Changes in medications or nutritional products during the study intervention must be documented. - Participation in another interventional study within 2 weeks of this study. - Patients with a clinical indication for a low fibre or fibre free diet as advised by the healthcare team. - Patients with known or suspected ileus or mechanical bowel obstruction

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Compleat 1.5 HP
Patients well established and stable on an enteral tube feed. This group will act as their own controls and switched to the new tube feed.

Locations

Country Name City State
United Kingdom Martha Van Der Linde Worcester

Sponsors (1)

Lead Sponsor Collaborator
Société des Produits Nestlé (SPN)

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Daily patient diaries Daily monitor of gastrointestinal tolerance using questionnaire on increase, decrease or no change 14 days
Primary Daily formula intake mL per day 14 days
See also
  Status Clinical Trial Phase
Completed NCT05592951 - Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers N/A
Completed NCT04689035 - A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144 Phase 1
Recruiting NCT02129296 - Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study Phase 1/Phase 2
Completed NCT06114524 - Effect of Binaural Beats on Level of Anxiety and Toleration in Patients Undergoing Upper Gastrointestinal Endoscopy Without Sedation N/A
Active, not recruiting NCT06286488 - Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza Phase 4
Completed NCT04529759 - Healthy Term Infants Fed Milk-Based Infant Formula N/A
Not yet recruiting NCT05428748 - Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers N/A
Completed NCT04499482 - Safety and Tolerability of Soy Fiber N/A
Recruiting NCT01207206 - Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients N/A
Completed NCT01038882 - Randomized Study With Midazolam for Sedation in Flexible Bronchoscopy N/A
Completed NCT05794100 - Evaluating the Impact of Different Sugar Replacer Combinations on Gastrointestinal Tolerance N/A
Completed NCT06187233 - The Effects of Binaural Beats on Pain, Anxiety, and Procedure Tolerance in Patients Undergoing Colonoscopy Without Sedation N/A
Completed NCT04055363 - Human Milk Oligosaccharides (HMOs) Post-market Study on Infants N/A
Recruiting NCT03707262 - Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor Phase 1/Phase 2
Completed NCT05585762 - Buck Institute Ketone Ester RCT N/A
Completed NCT02307773 - Lidocaine Spray on an Endoscope to Improve Tolerance to Endoscopy N/A
Completed NCT04188782 - Tolerance to Sevoflurane in Children Undergoing Repeated Drug Exposure
Recruiting NCT05527652 - Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia N/A
Recruiting NCT05088694 - The Optimization and Evaluation of the Extremism and Intolerance Curriculum for the Kingdom of Bahrain. N/A
Completed NCT02144402 - Growth of Healthy Term Infants Fed Formula Containing DHA-B N/A